Mechanistically, NEDD4-1 mediates tumor-suppressive effects through targeting pAkt-Ser473 for ubiquitination degradation, and suppressing PTEN/PI3K/Akt pathway (Huang et al., 2019). Here, NEDD4 is linked to neoplasm.